Zone | Class | OR gene | OR+ cells | Change | Paired t test | |
---|---|---|---|---|---|---|
Control | OMP-Cyp26B1 | |||||
Age PD14 | ||||||
Z1 | I | MOR40-14 | 32.04 ± 1.09 | 30.27 ± 0.63 | — | p > 0.05 |
Z1 | II | MOR161-6 (K21) | 31.39 ± 2.22 | 30.92 ± 5.62 | — | p > 0.05 |
Z1 | I | MOR18-2 (MOL2.3)* | 4.61 ± 1.34 | 13.19 ± 1.47 | ↑ | p < 0.001 |
Z2 | II | MOR263-5 (P2)* | 39.69 ± 9.07 | 57.33 ± 12.41 | ↑ | p < 0.001 |
Z2 | I | MOR35-1 | 34.14 ± 4.24 | 47.72 ± 4.84 | ↑ | p < 0.001 |
Z2-3 | II | MOR256-17 | 208.13 ± 12.88 | 124.75 ± 12.17 | ↓ | p < 0.001 |
Z3 | II | MOR256-55 (L45) | 73.24 ± 9.16 | 70.21 ± 5.80 | — | p > 0.05 |
Z4 | II | MOR235-1 (A16) | 111.26 ± 9.38 | 50.12 ± 7.24 | ↓ | p < 0.001 |
Z4 | II | MOR244-1 (MOR28) | 117.28 ± 5.12 | 16.27 ± 3.91 | ↓ | p < 0.001 |
Age E16.5 | ||||||
Z2-3 | II | MOR256-17 | 31.067 ± 1.16 | 29.39 ± 0.77 | — | p > 0.05 |
Age PD4 | ||||||
Z1 | I | MOR40-14 | 4.29 ± 0.26 | 4.39 ± 0.92 | — | p > 0.05 |
Z1 | II | MOR161-6 (K21) | 3.88 ± 0.39 | 3.57 ± 0.17 | — | p > 0.05 |
Z2 | II | MOR263-5 (P2) | 7.21 ± 1.12 | 7.72 ± 0.74 | — | p > 0.05 |
Z2 | I | MOR35-1 | 26.77 ± 8.19 | 29.67 ± 2.89 | — | p > 0.05 |
Z2-3 | II | MOR256-17 | 86.08 ± 14.51 | 47.50 ± 11.06 | ↓ | p < 0.001 |
Z4 | II | MOR235-1 (A16) | 33.29 ± 1.23 | 18.38 ± 0.67 | ↓ | p < 0.001 |
Z4 | II | MOR244-1 (MOR28) | 53.7 ± 13.74 | 26.14 ± 8.53 | ↓ | p < 0.001 |
OR expression frequencies are presented as mean OR+ cells ± SD per hemisection (n = 48), Student's t test, two tailed. Similar frequencies in control and Cyp26B1 mice are indicated with —; higher and lower frequencies in Cyp26B1 mice compared with control mice are indicated with ↑ and ↓, respectively.
↵*βgal+ cells quantified in heterozygous OR-reporter mice.